TRIM Activators
The TRIM (Tripartite Motif) family of proteins encompasses a diverse group of E3 ubiquitin ligases that are critically involved in various cellular processes, including intracellular signaling pathways, apoptosis, cell cycle regulation, and innate immunity. Characterized by the presence of a RING domain, one or two B-box domains, and a coiled-coil region, TRIM proteins function by facilitating the ubiquitination of target substrates, thereby marking them for degradation by the proteasome or altering their subcellular localization and activity. This ubiquitination process is essential for the regulated turnover of proteins, modulating signal transduction pathways and maintaining cellular homeostasis. The specificity and versatility of TRIM proteins allow them to play pivotal roles in antiviral defense, where they recognize and target viral proteins for degradation, and in the regulation of transcription factors and signaling molecules, influencing cell growth, differentiation, and response to stress.
The activation of TRIM proteins involves several layers of regulation, including post-translational modifications, subcellular localization, and protein-protein interactions. Phosphorylation, SUMOylation, and neddylation are among the post-translational modifications that can affect the E3 ligase activity of TRIM proteins, either by enhancing their ability to ubiquitinate substrates or by stabilizing the TRIM proteins themselves. The localization of TRIM proteins within the cell can also regulate their activity; for example, nuclear or cytoplasmic localization can determine the range of substrates available for ubiquitination. Furthermore, interactions with specific co-factors or substrates can modulate the activity of TRIM proteins, enabling them to respond dynamically to cellular signals and stress conditions. This intricate regulatory network ensures that TRIM proteins are activated in a context-dependent manner, allowing for precise control over protein ubiquitination and degradation pathways that are critical for cellular function and the immune response.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can then phosphorylate TRIM, potentially enhancing its E3 ubiquitin ligase activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, leading to an increase in intracellular cAMP and activation of PKA. Activated PKA may indirectly enhance the activity of TRIM by phosphorylation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent PKC activator that can modulate signaling pathways downstream of PKC. PKC-mediated phosphorylation pathways may lead to enhanced functional activity of TRIM by post-translational modifications. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor with antioxidant properties. By inhibiting certain kinases, EGCG may reduce competitive signaling, potentially leading to increased activity of TRIM-associated pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases, possibly resulting in enhanced TRIM activity through phosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell and potentially enhancing TRIM activity through phosphorylation-dependent mechanisms. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the SERCA pumps, leading to increased cytosolic calcium that may activate calcium-dependent kinases and indirectly enhance TRIM activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P engages with its receptors to activate intracellular signaling cascades, including those that may lead to the post-translational modification and activation of TRIM. | ||||||